Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
Dysport
Description:
A brand of botulinum toxin type A used medically to treat muscle spasms and for cosmetic reduction of wrinkles.
Primary topic:
Botulinum Toxin and Related Neurological Disorders (63%)
Related topics:
Botulinum Toxin and Related Neurological Disorders (63%),
Facial Rejuvenation and Surgery Techniques (9%),
Urinary Bladder and Prostate Research (7%)
OpenAlex ID:
keywords/dysport
Botulinum A Toxin Therapy: Neutralizing and Nonneutralizing Antibodies—Therapeutic Consequences
1997
·
Hilke Göschel
, Kai Wohlfarth
, et al.
·
Experimental Neurology
·
315
A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia
1998
·
T Odergren
, H Hjaltason
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
300
PDF
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of Three Doses of Botulinum Toxin Type A (Dysport) With Placebo in Upper Limb Spasticity After Stroke
2000
·
A. M. O. Bakheit
, A. F. Thilmann
, et al.
·
Stroke
·
296
PDF
Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.
2002
·
D Ranoux
, C Gury
, et al.
·
PubMed
·
265
Success of Repeat Detrusor Injections of Botulinum A Toxin in Patients with Severe Neurogenic Detrusor Overactivity and Incontinence
2004
·
Joachim Grosse
, Guus Kramer
, et al.
·
European Urology
·
252
Botulinum toxin (Dysport(R)) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study
2000
·
N Hyman
·
Journal of Neurology Neurosurgery & Psychiatry
·
248
PDF
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double‐blind, placebo‐controlled study
2005
·
Daniel Truong
, Drake D. Duane
, et al.
·
Movement Disorders
·
242
What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport
1998
·
W Poewe
, G Deuschl
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
217
PDF
A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice
2001
·
K.R Aoki
·
Toxicon
·
216
A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke
2001
·
A. M. O. Bakheit
, S. Pittock
, et al.
·
European Journal of Neurology
·
216
Gummy smile and botulinum toxin: A new approach based on the gingival exposure area
2010
·
Rosemarie Mazzuco
, Dóris Hexsel
·
Journal of the American Academy of Dermatology
·
210
A Double-Blind Randomised Placebo-Controlled Evaluation of Three Doses of Botulinum Toxin Type A (Dysport®) in the Treatment of Spastic Equinovarus Deformity after Stroke
2003
·
S.J. Pittock
, A.P. Moore
, et al.
·
Cerebrovascular Diseases
·
209
DYSBOT: A single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1
1997
·
Cristina Sampaio
, Joaquim J. Ferreira
, et al.
·
Movement Disorders
·
207
A randomized trial of botulinum toxin A for treatment of drooling
2003
·
A. Lipp
, T. Trottenberg
, et al.
·
Neurology
·
199
Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms.
1997
·
P Schnider
, M Binder
, et al.
·
PubMed
·
197
Pharmacology of botulinum toxin: differences between type A preparations
2006
·
R. L. Rosales
, H. Bigalke
, et al.
·
European Journal of Neurology
·
192
A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines
2004
·
Benjamin Ascher
, Benjamin Zakine
, et al.
·
Journal of the American Academy of Dermatology
·
183
Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport®) for the relief of upper back myofascial pain syndrome: Results from a randomized double-blind placebo-controlled multicentre study
2006
·
Hartmut Göbel
, Axel Heinze
, et al.
·
Pain
·
180
Immunological aspects of Botox ® , Dysport ® and Myobloc TM /NeuroBloc ®
2006
·
D. Dressler
, M. Hallett
·
European Journal of Neurology
·
175
Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm
1997
·
Zita Nüβgens
, Peter Roggenkämper
·
Graefe s Archive for Clinical and Experimental Ophthalmology
·
175
Studies on the dissociation of botulinum neurotoxin type A complexes
2010
·
Karl-Heinz Eisele
, Klaus Fink
, et al.
·
Toxicon
·
168
Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study
2002
·
R Baker
, M Jasinski
, et al.
·
Developmental Medicine & Child Neurology
·
168
PDF
Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity
2008
·
R. L. Rosales
, A. S. Chua-Yap
·
Journal of Neural Transmission
·
163
Pharmacology of therapeutic botulinum toxin preparations
2007
·
Dirk Dressler
, Reiner Benecke
·
Disability and Rehabilitation
·
161
Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®
2010
·
Jürgen Frevert
·
Drugs in R&D
·
156
PDF
Show more works
View as search
Works count:
895
Citation count:
17,730
Year
Topic
Type
